Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicTargeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyInvestigational drugs to treat methicillin-resistant Staphylococcus aureusWill there ever be a universal Staphylococcus aureus vaccine?Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyCommunity-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidinNovel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury.The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.The bicomponent pore-forming leucocidins of Staphylococcus aureusPrompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genesIncreased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulinRelative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatantsStaphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates.Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.Antibiotic options for treating community-acquired MRSA.Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study.Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxinsAntimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee.Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxinsPanton-Valentine leukocidin in community and hospital-acquired Staphylococcus aureus strains.Pneumonia and new methicillin-resistant Staphylococcus aureus clone.The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections.Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology.Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.Community-acquired pneumonia and bacteremia due to methicillin-resistant Staphylococcus aureus carrying Panton-Valentine-leukocidin gene in Greece: two case reports and literature review.Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.Pneumonia caused by methicillin-resistant Staphylococcus aureus.A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in CanadaStaphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps.Community-associated Staphylococcus aureus infections in children.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Panton-Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature.Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports.Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection.The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.
P2860
Q24614464-2B18D598-F9D5-4BC5-B874-DB7160636973Q26752975-D37648B1-C026-4E81-BAD2-7F906965776CQ26780246-A32EC839-865F-4460-9B2F-E4236871E1CEQ26824837-84929C74-38A2-403F-A203-B583E6BE0A5EQ28235095-A7F82E9B-D8A6-4236-9918-9F4A603B70F6Q28277284-FAEBECE1-6D2B-4CA9-9AC7-457C90D4250FQ30370676-C84DE289-3760-4DFC-8CFF-0B68B2CA200FQ30386697-59E7A516-6FBF-481A-A3C8-F0E9CAED5F3AQ30415990-BABA847C-26D6-4174-A7E1-E6BC38D36FCCQ33716613-9B51B33B-876A-47FE-B85A-C7E449383504Q33719836-1613B641-24FA-45D6-9613-F1FF0FFC45CAQ33743499-0E3DEF07-FCDE-4322-BE24-BE8F9FFF94CDQ33827110-57C056B6-CA16-42C3-9369-EA9EE74CAE90Q33880228-AB470F3F-6697-4416-AC5F-C9165556247DQ33905654-C32723E2-78DD-47AE-B5E7-0E27F47CDA12Q34097530-0C0EA551-C2FB-4592-A0BF-81A186B00D48Q34105297-0E58262B-64A2-40B1-B22A-66173522AAE5Q34407240-3D94B027-9438-4838-9420-73CFFEC36E9EQ34593646-028D8B63-2236-47CF-A707-A5D75E90FF21Q34979082-2CEE7089-AB24-4805-B2B1-DED803875700Q35047035-B78D5444-C32D-4FAC-A0EB-5FAD0438CC15Q35107040-FEC7BB3A-85F0-4B64-9126-064411CA5696Q35221057-D2724878-3C7F-4BEB-A52F-E4EF419F4875Q35239977-0D547272-B44C-4AF7-BAD1-5868205DDEDBQ35613368-31002D66-1B9B-49CE-863C-16D81743F3ADQ35793992-9210FDF8-9D5D-4528-A9EA-E3447A150CE8Q36242617-1ED4F16C-38CD-4B70-89BF-0C0A0DE14DD1Q36245190-3F4C357B-7DFA-4182-9A04-064050192895Q36563779-4D55578B-E2CC-46CA-9782-CAF96E50397CQ37071325-7B9EE819-0C9C-4D4E-B456-6DDAF0471756Q37109817-BFB5B81C-68DB-45CB-9FD8-5ADA2609CB35Q37156705-BFF91746-D118-45D2-A3E2-A5A9CE0A162DQ37333745-D554CA29-6180-40DD-B671-83786A523BE6Q37520251-9F76B3AE-4488-4C3D-93E9-93785D2E8E65Q37747396-45526108-412C-45EE-9EA7-341F3FAED2DCQ37819539-F794086F-7753-44EE-BEB2-3118E8F980CEQ37967231-6EFD7FE3-6497-42D9-A4FC-F5CB2C206AA6Q37970828-8495097E-AB10-4A24-8E88-B226384385A2Q38145284-17A3A28A-D85A-4250-9B28-321954EAD433Q38671478-CEAF5AC1-5E2F-496F-8030-8C15E9FF7608
P2860
Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@en
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@nl
type
label
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@en
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@nl
prefLabel
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@en
Neutralization of Staphylococc ...... enous immunoglobulin in vitro.
@nl
P2093
P356
P1476
Neutralization of Staphylococc ...... venous immunoglobulin in vitro
@en
P2093
Anne-Laure Genestier
Gregoire Cozon
Jerome Etienne
Nathalie Eyssade
Simone Peyrol
Valérie Gauduchon
P304
P356
10.1086/380909
P407
P577
2004-01-09T00:00:00Z